3-month Aerobic and Resistance Exercise Intervention for Individuals Diagnosed With Melanoma
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS
- Status
- UNKNOWN
- Phase
- N/A
Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1
CAcTUS - Circulating Tumour DNA Guided Switch
- Status
- UNKNOWN
- Phase
- PHASE2
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
- Status
- WITHDRAWN
- Phase
- N/A
Preclinical Validation of New Anti-melanoma Compounds
- Status
- COMPLETED
- Phase
- N/A
Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology
- Status
- UNKNOWN
- Phase
- N/A
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Targeted Radionuclide Therapy for Metastatic Melanoma [131I] ICF01012
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed
- Status
- COMPLETED
- Phase
- N/A
An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma.
- Status
- WITHDRAWN
- Phase
- PHASE2
Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Intralesional Sclerosant for in Transit and Cutaneous Melanoma Metastases
- Status
- WITHDRAWN
- Phase
- PHASE2
Intratumoral Injection of Autologous CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Talimogene Laherparepvec (T-VEC)
- Status
- UNKNOWN
- Phase
- PHASE1
SunSmart Intervention in Schools
- Status
- COMPLETED
- Phase
- NA
Nivolumab, BMS-936558 in Combination with Relatlimab, BMS-986016 in Patients with Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting
- Status
- COMPLETED
- Phase
- PHASE2